Abstract: Melanoma incidence is growing worldwide. Although recent advances in imaging, there is not still available a specific melanoma agent that can be used for melanoma staging. Archaeosomes may be defined as liposomes composed of one or more polar lipids extracted from the Archaea domain (Archaebacterium). As liposomes have been used as vehicles for drugs and isotopes, the aim of this work is to evaluate radiolabelled 99mTc-archaeosomes as a potential melanoma imaging agent. and evaluate its potential role as a melanoma imaging agent. Archaeosomes were prepared by handshaken method and were radiolabeled with 99m Tc; radiolabelling efficiency and purity were evaluated through different chromatographic systems. In vitro stability of 99m Tc-diethylene-triamine-pentaacetate (DTPA)-archaeosomes was performed through L-cysteine challenge. Archaeosome size distribution was determined by laser light scattering, having nanometer size between 90 and 120 nm. Radiolabelling efficiency was >90%; 99m Tc-DTPAarchaeosomes presented a radiochemical purity superior to 80% evaluated 24 h post-radiolabelling. For the highest concentration of L-cysteine (30 mM) and 1 h incubation, radiochemical purity was 92.90%, 6.41% was bound to cysteine, and 0.69% remained as 99m TcO 4 -. Biodistribution and scintigraphic imaging studies in healthy C57 black mice showed high liver, spleen uptake, and renal elimination. Melanoma bearing mice had similar biodistribution as healthy mice but increased melanoma uptake, with T/M ratio of 46 ± 3.7. Our results show the feasibility of 99m Tc radiolabelling archaeosomes and their potential role as a melanoma imaging agent.
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Abstract: Melanoma incidence is growing worldwide. Although recent advances in imaging, there is not still available a specific melanoma agent that can be used for melanoma staging. Archaeosomes may be defined as liposomes composed of one or more polar lipids extracted from the Archaea domain (Archaebacterium). As liposomes have been used as vehicles for drugs and isotopes, the aim of this work is to evaluate radiolabelled 99mTc-archaeosomes as a potential melanoma imaging agent. and evaluate its potential role as a melanoma imaging agent. Archaeosomes were prepared by handshaken method and were radiolabeled with 99m Tc; radiolabelling efficiency and purity were evaluated through different chromatographic systems.
In vitro stability of 99m
Tc-diethylene-triamine-pentaacetate (DTPA)-archaeosomes was performed through L-cysteine challenge. Archaeosome size distribution was determined by laser light scattering, having nanometer size between 90 and 120 nm. Radiolabelling efficiency was >90%; 99m Tc-DTPAarchaeosomes presented a radiochemical purity superior to 80% evaluated 24 h post-radiolabelling. For the highest concentration of L-cysteine (30 mM) and 1 h incubation, radiochemical purity was 92.90%, 6.41% was bound to cysteine, and 0.69% remained as 99m . Biodistribution and scintigraphic imaging studies in healthy C57 black mice showed high liver, spleen uptake, and renal elimination. Melanoma bearing mice had similar biodistribution as healthy mice but increased melanoma uptake, with T/M ratio of 46 ± 3.7. Our results show the feasibility of 99m Tc radiolabelling archaeosomes and their potential role as a melanoma imaging agent.
Introduction
Archaeosomes may be defined as liposomes composed of one or more polar lipids extracted from Archaea domain (Archaebacterium). Although Archaea and Bacteria are both prokaryotes, Archaea is more closely related to Eucarya domain than bacteria [1] . Archaea polar lipids can be composed by a core of archaeol or caldarqueol, or a mixture of both [2] , structures of archaeobacterial membrane lipids [3] . Polar heads lipids (phospho glycol, amine, and hydroxyl) of Archaea are similar to those found in phosphatidylcholine from Eukaryotes and Bacteria; however, esther lipids are rarely seen in Archaea. Archaeol membrane lipids are monopolar and caldarchaeol lipids are bipolar. Archea extracts have a net negative charge, due to the predominance of negatively polar head groups in the lipids [2] . In the same way as phospholipids, archaeolipids, in contact with water form flat bilayers that with the addition of energy, are sealed and form vesicles [4] .
Liposomes are more susceptible to hydrolysis by the presence of ester bonds, oxidation due to the presence of unsaturations, and content loss. Otherwise, archeosomes have greater structural strength in hostile environments [5] . Therefore, archeosomes may play an interesting role in chemotherapy as a potential drug carrier [6] [7] [8] [9] . It has also been reported that archaeosomes have an important adjuvant activity in vivo [10] . This adjuvant activity correlates to macrophages and dendritic cells recruitment and activation. If archeosomes can be used to deliver drugs to tumors, they could also be radiolabeled to be used as an imaging agent. The aim of this work is to evaluate radiolabelled 99m Tc-archaeosomes as a potential melanoma imaging agent.
Materials and methods
Archaeosomes synthesis
Archaeosomes were prepared by handshaken method [11, 12] . Halorubrum tebenquichense Archae lipids were extracted from frozen and thawed biomass, with Cl 3 CH:CH 3 OH:H 2 O (1:2:0.9; v: v), and the total polar lipid fraction was collected by precipitation from cold acetone (kindly donated by PhD. Eder Romero Laboratory UNQ, Argentina). Typically 11 mg of extracted lipids from Archaea and 2 mg estearilamide-diethylene-triamine-pentaacetate (DTPA) (in-house synthesis) were added in chloroformmethanol (2: 1 v/v) medium to a round bottom flask. Lipids were rota-evaporated to dryness in 60°C water bath at 120 rpm. The obtained film was hydrated with 5 ml of bidistilled water. Then, multilamellar large vesicles obtained were extruded through a series (11, 0.4 μm, and 11, 0.2 μm) of polycarbonate filters to form unilamellar archaesomes. Particle size distribution was determined by laser light scattering Nano Zetasizer ZS (Malvern) located at Facultad de Química, UdelaR.
Radiolabelling and physicochemical controls
Pre-formed archaeosomes were radiolabelled with 
In vitro stability
99m Tc-archaeosomes (0.4 mL) prepared as previously described were challenged against 0.4 mL of different solutions of L-cysteine (Sigma) [13] [14] [15] . The final concentrations of L-cysteine obtained were 0.1, 10, and 30 mM. Different mixtures were incubated for 3 h at 37°C. Controls were carried out in the following chromatographic systems: ITLC-SG/NaCl 0.9% (Rf:
99m TcO 
Cell culture and animal model
B16-F1 murine melanoma cell line obtained from the American Type Culture Collection was maintained in Dulbecco's modified Eagle's medium (PAA Laboratories GmbH, Pasching, Austria) supplemented with 10% fetal bovine serum (PAA Laboratories GmbH) and 2 mM glutamine (AppliChem GmbH, Darmstadt, Germany). 6-week-old C57BL/6 mice (URBE, Uruguay) were used in all experiments. Melanomas were induced in mice by subcutaneous injection of 2.5 × 10 5 B16-F1 melanoma cells in 0.1 ml of phosphate-buffered saline in the right flank. After 2 weeks of inoculation, tumors were palpable (1 cm 3 ) and mice were ready for biodistribution and scintigraphic studies. All mentioned protocols were approved by our Animal Experimentation National Committee for (CHEA, Uruguay).
Biodistribution studies
Biodistribution studies were carried out after intravenous injection of 99m Tc-archaeosomes 6.5 ± 1.2 MBq (176 ± 33 µCi) in physiological serum as vehicle to melanoma bearing mice, as well as to C57BL/6 normal mice. Biodistribution was performed at 4 h and 24 h, and 8 animals were used by time point (4 normal mice and 4 melanoma bearing mice). Animals were sacrificed by cervical dislocation; tissues and organs of interest were harvested and washed with distilled water to remove blood excess and weighted. Activity was measured using a solid scintillation counter (ORTEC), and the activity found in each organ was presented as a percentage of the total dose injected per gram (%DI/g) of tissue or organ. To calculate the gross correlation between the distribution of normal mice and melanoma bearing mice, it was compared the acquisition of 99m Tc-arqueosomas expressed as a percentage of the injected dose % ID.
Images
Scintigraphic images were carried out in normal and melanoma bearing C57BL/6 mice (n = 4). Images were acquired with a gamma camera (model Sophy DSX, Sopha Medical, Buc, France, connected in series with a computational system, Mirage Segami, Columbia, MD). The equipment consisted of a large field of view rectangular gamma camera (Sophy DSX, Sopha Medical) fitted with a low-energy, high-resolution collimator. Planar images of mice were acquired on a 256 × 256 matrix, using a 15% window centered on an energy peak of 140 keV. Mice were injected with 22.2 MBq (0.6 mCi) of 99m Tc-archaeosomes through tail vein and anesthetized by intraperitoneal injection of ketamine-Xilazina (100-10 mg/kg). Mice were imaged 4 h post-administration of the radiolabelled compound. Region of interest (ROI) was placed over tumor region and compared against contralateral flank (tumor/healthy tissue ratio).
Results
Characterization of the archaeosomes
Archaeosome size distribution was determined by laser light scattering Nano Zetasizer ZS, having nanometer size between 90 and 120 nm [ Figure 1 ]. Radiolabelling efficiency and purity were evaluated through the mentioned chromatographic systems, having a radiolabelling efficiency >90%.
99m Tc-DTPAarchaeosomes presented a radiochemical purity superior to 80% evaluated 24 h post-radiolabelling. Furthermore, archaeosomes in the molecular exclusion chromatography (column PD-10 G-25) were obtained at 3.0-3.5 mL of elution while 99m TcO 4 -was eluted at 6.0-6.5 mL.
In vitro stability
In vitro stability of 99m Tc-DTPA-archaeosomes was performed through L-cysteine challenge. At 0.1 mM cysteine concentration and 1 h incubation, 96% ± 2.1 99m Tc remained attached to archaeosomes, 0.82 ± 0.09% was bound to cysteine, and 3.15 ± 0.16% remained as Tc remained bound to archaeosomes, while 0.11 ± 0.01% and 2.55± 0.13% were attached to cysteine and 99m TcO 4 -, respectively. At 10 mM cysteine concentration and 1 h incubation, radiochemical purity was 91 ± 2.0%, while 3.2 ± 0.1% and 6.4 ± 0.08% of 99m Tc were attached to cysteine and 99m TcO 4 -, respectively, at 3 h of incubation, 70.9 ± 1.6%
99m Tc remained attached to archaeosomes, 28 ± 1.3% was bound to cysteine, and 1.1 ± 0.05% remained as 99m TcO 4 -. For the highest concentration of cysteine (30 mM) and 1 h incubation, radiochemical purity was 92.90 ± 7.01%, 6.41 ± 0.19% was bound to cysteine, and 0.69 ± 0.12% remained as 99m TcO 4 -. At 3 h of incubation, 64.9 ± 3.17% of 99m Tc remained bound to archaeosomes, while 32 ± 0.38% and 3.1 ± 0.13% were attached to cysteine and 
Biodistribution studies
Biodistribution results of 99m Tc-DTPA-archaeosomes in normal C57BL/6 mice at 4 h and 24 h are shown in Figure 3 . These studies show that 99m Tc-DTPAarchaesomes have an important hepatic uptake (17.72% ± 5.4 and 25.43% ± 4.0) at 4 and 24 h, respectively. Furthermore, it was evidenced spleen uptake (10.84% ± 0.7 and 14.71% ± 2.3) at 4 and 24 h, respectively. Kidney uptake was 4.45% ± 1.25 and 3.02% ± 0.29 at 4 and 24 h, respectively. These results are consistent with a high blood clearance at 4 h (0.93% ± 0.37), showing low activity blood levels at 24 h (0.92% ± 0.37%).
M e l a n o m a b e a r i n g m i c e p r e s e n t e d a s i m i l a r biodistribution pattern than the one observed in normal C57BL/6 mice. It was also observed high liver (19.0 ± 6.5 and 19.4% ± 1.89) and spleen uptake (13.36 ± 0.24 and 3.62 ± 1.56) at 4 and 24 h, respectively [ Figure 4 ]. Kidney uptake was 2.54% ± 1.62 at 4 h and 3.0 ± 1.0% at 24 h. At 24 h, tumor uptake was 0.83 ± 0.27, with a tumor/muscle ratio of 5 at 4 h, increasing to a ratio of 34 at 24 h.
Images
Scintigraphic studies of 99m Tc-DTPA-archaesomes in C57BL/6 normal and melanoma-bearing mice at 4 hshow important abdominal uptake that correlates with liver, spleen, and kidney uptake. Furthermore, bladder activity was observed in both the studies. In melanoma-bearing mice, there was an important tumor uptake. ROI (tumor/healthy tissue) ratio was 46.6 ± 3.7 [ Figure 5 ].
Discussion
Cancer of the skin is by far the most common of all cancers. It is estimated that the annual increase in the incidence rate of melanoma has been approximately 3-7% per year worldwide for Caucasians [16] . Concerning melanoma mortality by 2012, Europe's rate of 1.5/100 000 (person-years) is the third highest in the World, Tc-diethylene-triamine-pentaacetatearchaesosomes. Results are presented as % Act/g mean and ±1 standard deviation error bar.
after Australia/New Zealand (3.5/100 000) and North America (1.7/100 000) [17] . Studies have confirmed that extensive radiologic studies such as computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), PET-CT, and bone scans have an extremely low yield in asymptomatic patients with primary cutaneous melanoma and are generally not indicated [18, 19] . These results highlight the need of novel imaging modalities or tracers able to stage melanoma patients. In this way, we have developed 99m Tc radiolabeled archaeosomes aiming to be used as a melanoma imaging agent. Our results demonstrate that archaeosomes can be synthesized using a similar approach as the one described to syntethize liposomes [20] . We a l s o o b s e r v e d t h a t e t h e r p o l a r l i p i d s o f archaeobacteria can be used in either a fluid or a liquidcrystalline state [21] . Therefore, it is possible to work in the film hydration phase at room temperature, thus simplifying its synthesis. Another advantage of these lipids is that they do not oxidate in the presence of air since phytane chains are saturated. This allows us to store them at room temperature and in the presence of oxygen. In addition, these lipids are characterized by high thermal stability [22] , so they can be sterilized by autoclave which is an advantage for their in vivo applications. Radiolabelling DTPA-archaeosomes were achieved following the simple procedure at room temperature, resulting in 90% of PRQ, maintained superior to 80% at 24 h post-labelling.
99m Tc-DTPA-archaeosomes were challenged against increased concentration of cysteine, being stable at all concentrations studied at 1 h. Even with a concentration of 0.1 mM at 3 h, radiochemical purity was superior to 90%. At higher cysteine concentrations than the ones found in plasma (10 and 30 mM), radiolabeled archaeosomes were not so stable [ Figure 2 ] [23] . In terms of in vivo stability, this system proved to have a high blood clearance due to mononuclear phagocyte system capture as biodistribution and scintigraphic images show. There is high liver (25.36 ± 4.0 and 19.41 ± 1.9) and spleen (14.69 ± 2.3 and 3.61 ± 1.5) uptake in normal and melanoma-bearing mice, and also, there are elements of biliary excretion that explains the intestinal activity. Furthemore, we found lesser degree elements of urinary elimination (kidney and bladder uptake). Liver and spleen uptake is not due to blood destabilization caused by high-density lipoproteins (HDL), as seen with liposomes. HDL is responsible for the removal from liposomes of the phospholipids present in the outer side of the bilayer formed by ester like lipids [24] . Furthermore, archaesomes present ether bonds, while liposomes have ester bonds. It should be mentioned that the radioactive complex itself is stable in vivo, without evidencing a change in 99m Tc-DTPAarchaesomes biodistribution profile [ Figures 3 and 4 ] [25] . Biodistribution studies of melanoma-bearing mice at 4 and 24 h showed tumor uptake, having a tumor/ muscle (T/NT) ratio of 5 at 4 h and 34 at 24 h with high blood clearance. These results are comparable to the ones reported for radiolabeled antibodies for tumor detection [26] . Similar results were found in scintigraphic images, were tumor/muscle (T/NT) ratio was approximately 46 at 4 h. We also found abdominal uptake due to mainly liver, spleen, and gastrointestinal activity without considerable muscle uptake. Arcaheosomes melanome accumulation maybe due to enhanced permeability and retention effect (EPR). This effect is highly dependent on size, being more effective between 100 and 200 nm [27] . Our synthetized 99m Tc radiolabeled archaeosomes range from 90 to 120 nm making EPR possible. 99m Tc-DTPA-archaeosomes showed higher tumorspecific accumulation, compared to similar 99m Tc-DTPA-liposomes, where T/M ratio was approximately 4 at 4 h while in radiolabeled archaeosomes was 46 [20] . This striking difference may be due to EPR effect and also by macrophages present in tumor microenvironment that are involved in their elimination. Macrophages do not recognize liposomes [28] . If so, 99m Tc radiolabeled archaeosomes could be used for sentinel node procedures. This hypothesis will be studied in depth in future research. Taking into account 99m Tc-DTPA-archaeosome biodistribution and scintigraphic images, maybe it would be of interest to use it as a head and neck melanoma agent due to the fact of the low uptake in these structures and the high melanoma uptake. We must consider the high incidence of this kind of tumors, 10-20% of all cutaneous melanomas arise in the head and neck region, the incidence in this area has similarly increased, from 2 per 100,000 in 1996 to 2.7 per 100,000 in 2001 [29] .
Conclusion
Our results describe, for the first time, the feasibility of 99m Tc radiolabeling of archaeosomes. It was performed in an easy and simple way, and our results indicate that it can be used as a potential melanoma imaging agent, highlighting its potential role in head and neck melanomas. Furthermore, these same concepts could be applied to other solid tumors and for sentinel node procedures.
Conflict Of Interest
The authors declares that there is no conflict of interest regarding the publication of this paper.
